Sobi Receives Approval from Health Canada for Empaveli™ (pegcetacoplan) for the Treatment of Certain…
The first targeted C3 therapy approved in CanadaApproval based on results from head-to-head PEGASUS phase 3 study where Empaveli™ demonstrated superiority to eculizumab in improving hemoglobin levels1On trial, transfusion avoidance was…